Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Digital phenotyping approaches and mobile devices enhance CNS biopharmaceutical research and development.

Literature DB >> 30267015

Digital phenotyping approaches and mobile devices enhance CNS biopharmaceutical research and development.

Daniel G Smith¹.

Abstract

Mesh：

Substances：

Year: 2018 PMID： 30267015 PMCID： PMC6224520 DOI： 10.1038/s41386-018-0222-6

Source DB: PubMed Journal: Neuropsychopharmacology ISSN： 0893-133X Impact factor: 7.853

× No keyword cloud information.

15 in total

1. Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers.

Authors: Brett A Clementz; John A Sweeney; Jordan P Hamm; Elena I Ivleva; Lauren E Ethridge; Godfrey D Pearlson; Matcheri S Keshavan; Carol A Tamminga
Journal: Am J Psychiatry Date: 2015-12-07 Impact factor: 18.112

2. Relapse prediction in schizophrenia through digital phenotyping: a pilot study.

Authors: Ian Barnett; John Torous; Patrick Staples; Luis Sandoval; Matcheri Keshavan; Jukka-Pekka Onnela
Journal: Neuropsychopharmacology Date: 2018-02-22 Impact factor: 7.853

3. The digital mental health revolution: Opportunities and risks.

Authors: Amir Tal; John Torous
Journal: Psychiatr Rehabil J Date: 2017-09

Review 4. Precision psychiatry: a neural circuit taxonomy for depression and anxiety.

Authors: Leanne M Williams
Journal: Lancet Psychiatry Date: 2016-04-14 Impact factor: 27.083

5. Realizing the potential of mobile mental health: new methods for new data in psychiatry.

Authors: John Torous; Patrick Staples; Jukka-Pekka Onnela
Journal: Curr Psychiatry Rep Date: 2015-08 Impact factor: 5.285

6. Resting-state connectivity biomarkers define neurophysiological subtypes of depression.

Authors: Andrew T Drysdale; Logan Grosenick; Jonathan Downar; Katharine Dunlop; Farrokh Mansouri; Yue Meng; Robert N Fetcho; Benjamin Zebley; Desmond J Oathes; Amit Etkin; Alan F Schatzberg; Keith Sudheimer; Jennifer Keller; Helen S Mayberg; Faith M Gunning; George S Alexopoulos; Michael D Fox; Alvaro Pascual-Leone; Henning U Voss; B J Casey; Marc J Dubin; Conor Liston
Journal: Nat Med Date: 2016-12-05 Impact factor: 53.440

7. Detection of Motor Impairment in Parkinson's Disease Via Mobile Touchscreen Typing.

Authors: Teresa Arroyo-Gallego; Maria Jesus Ledesma-Carbayo; Alvaro Sanchez-Ferro; Ian Butterworth; Carlos S Mendoza; Michele Matarazzo; Paloma Montero; Roberto Lopez-Blanco; Veronica Puertas-Martin; Rocio Trincado; Luca Giancardo
Journal: IEEE Trans Biomed Eng Date: 2017-02-20 Impact factor: 4.538

Review 8. Technology in Parkinson's disease: Challenges and opportunities.

Authors: Alberto J Espay; Paolo Bonato; Fatta B Nahab; Walter Maetzler; John M Dean; Jochen Klucken; Bjoern M Eskofier; Aristide Merola; Fay Horak; Anthony E Lang; Ralf Reilmann; Joe Giuffrida; Alice Nieuwboer; Malcolm Horne; Max A Little; Irene Litvan; Tanya Simuni; E Ray Dorsey; Michelle A Burack; Ken Kubota; Anita Kamondi; Catarina Godinho; Jean-Francois Daneault; Georgia Mitsi; Lothar Krinke; Jeffery M Hausdorff; Bastiaan R Bloem; Spyros Papapetropoulos
Journal: Mov Disord Date: 2016-04-29 Impact factor: 10.338

9. Psychiatric drug development: diagnosing a crisis.

Authors: Steven E Hyman
Journal: Cerebrum Date: 2013-04-02

10. Patient Smartphone Ownership and Interest in Mobile Apps to Monitor Symptoms of Mental Health Conditions: A Survey in Four Geographically Distinct Psychiatric Clinics.

Authors: John Torous; Steven Richard Chan; Shih Yee-Marie Tan; Jacob Behrens; Ian Mathew; Erich J Conrad; Ladson Hinton; Peter Yellowlees; Matcheri Keshavan
Journal: JMIR Ment Health Date: 2014-12-23

4 in total